November 21, 2025 — Leads & Copy — Hyperfine, Inc. (Nasdaq: HYPR) will present at the upcoming Piper Sandler 37th Annual Healthcare Conference on Thursday, December 4th, at 8:10 a.m. Eastern Time (ET).
A live audio webcast and an archived recording will be accessible on Hyperfine, Inc.’s corporate website’s Investors page.
Management will also host in-person meetings. Those interested in scheduling a meeting should contact their Piper Sandler representative or the investor contact provided.
The Swoop® Portable MR Imaging® Systems are U.S. Food and Drug Administration (FDA) cleared for brain imaging of patients of all ages. The portable, ultra-low-field magnetic resonance imaging devices produce images displaying the internal structure of the head where a full diagnostic examination is not clinically practical. When interpreted by a trained physician, the images provide information useful in determining a diagnosis.
Hyperfine, Inc. (Nasdaq: HYPR) has redefined brain imaging with the Swoop® system—the first FDA-cleared, portable, ultra-low-field, magnetic resonance brain imaging system providing imaging at multiple points of professional care. Hyperfine, Inc.’s mission is to revolutionize patient care globally through transformational, accessible, clinically relevant diagnostic imaging. Founded by Dr. Jonathan Rothberg in a technology-based incubator called 4Catalyzer, Hyperfine, Inc. scientists, engineers, and physicists developed the Swoop® system out of a passion for redefining brain imaging methodology and how clinicians can apply accessible diagnostic imaging to patient care.
The Hyperfine logo, Swoop, and Portable MR Imaging are registered trademarks of Hyperfine, Inc. The Swoop logo, Optive AI logo, and Optive AI are trademarks of Hyperfine, Inc.
Investor Contact:
Email: (Contact information not provided in the press release)
Telephone: (Contact information not provided in the press release)
Source: Hyperfine, Inc.
